NTHI NeOnc Technologies Holdings, Inc.
NeOnc Technologies Holdings, Inc. (NTHI) is expected to report earnings on November 9, 2026, before the market open. The consensus earnings estimate is a loss of $0.16 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +21.6% since its last earnings release on August 10, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About NeOnc Technologies Holdings, Inc.
NeOnc Technologies Holdings Inc. is a biotechnology company focused on creating novel drugs and delivery methods for pharma-based therapeutics which target brain and central nervous system diseases. The company's principal product portfolio includes NEO 100. NeOnc Technologies Holdings Inc. is based in LOS ANGELES.
Sector
Healthcare
Industry
Biotechnology